CardioMech

CardioMech AS is a medical device company developing a transfemoral, transseptally delivered mitral valve chordal repair technology. Their device is an artificial chord designed to reduce or eliminate regurgitation and restore native anatomy, offering a less-invasive alternative to open-heart surgery for mitral regurgitation patients. This catheter-based therapy aims to improve the standard of care for millions suffering from this condition.

Funding Round:

Funding Amount: $13M

Date: 02-Jan-2024

Investors: existing investors, new investors, a non-disclosed strategic investor

Markets: Medical Device, Cardiovascular, Surgical Devices, HealthTech

HQ: Trondheim, Norway

Founded: 2015

Website: https://www.cardiomech.com/

LinkedIn: https://www.linkedin.com/company/cardiomech/

Twitter:

Instagram:

Facebook:

Crunchbase: https://www.crunchbase.com/organization/cardiomech?utm_source=linkedin&utm_medium=referral&utm_campaign=linkedin_companies&utm_content=profile_cta_anon&trk=funding_crunchbase

Pitchbook: https://pitchbook.com/profiles/company/266203-99


Similar Startups


Leave a Comment

    🔷 Buy VC Database 🟩 Buy Startup Database 🎁 Get Free Sample

    Share this: